Skip navigation

Develop Strategic Solutions to Streamline Regulatory Submissions, Reduce Cost and Compress Timelines

March 28-29, 2018
  • Philadelphia, PA

Imaging can make or break a trial by representing the efficacy of a drug or a medical device. Join us for CBI’s Imaging in Clinical Trials — a two-day program that aims to explore current challenges, advancements and the opportunities that imaging data presents in clinical trials.

CBI is bringing together leaders from pharma, biotech, CROs and vendors to share insights on imaging best practices and methodologies utilizing new technologies. Attendees will walk away with strategies that they can apply to more effectively aggregate, analyze and apply imaging data to enhance pre-clinical research and clinical trials.

Benefit from Insightful Presentations and Related Networking / Problem-Solving that Looks at:

  • Best practices for imaging protocol design across sponsors,
    sites and core labs
  • Key business issues, workflow challenges and technology
    considerations to keep in mind when designing a trial
    with imaging endpoints
  • Preparations for audits
  • Updates on FDA guidance
  • Innovative technologies that could solve current challenges
  • Cloud-based solutions allowing for data acquisition and
    tracking trials
  • Data management tools and strategies that support
    regulatory submission
  • Managing imaging data in global trials

Previous Attendee Acclaim:

This is a phenomenal experience to interact with and listen to best practices of industry colleagues.

Merck

CBI assembled a true group of experts that present the material in a way that was easy to understand and
generated great discussion.

Bayer

Great representation of various aspects (pharma + services). This is a great meeting to share best practices and network.

Cleveland Clinic

Greatly benefitted from this conference’s overall context from data management to read — very informative.

Stanford University

Imaging in Clinical Trials

Develop Strategic Solutions to Streamline Regulatory Submissions, Reduce Cost and Compress Timelines

Imaging can make or break a trial by representing the efficacy of a drug or a medical device. Join us for CBI’s Imaging in Clinical Trials — a two-day program that aims to explore current challenges, advancements and the opportunities that imaging data presents in clinical trials.

CBI is bringing together leaders from pharma, biotech, CROs and vendors to share insights on imaging best practices and methodologies utilizing new technologies. Attendees will walk away with strategies that they can apply to more effectively aggregate, analyze and apply imaging data to enhance pre-clinical research and clinical trials.

Benefit from Insightful Presentations and Related Networking / Problem-Solving that Looks at:

  • Best practices for imaging protocol design across sponsors,
    sites and core labs
  • Key business issues, workflow challenges and technology
    considerations to keep in mind when designing a trial
    with imaging endpoints
  • Preparations for audits
  • Updates on FDA guidance
  • Innovative technologies that could solve current challenges
  • Cloud-based solutions allowing for data acquisition and
    tracking trials
  • Data management tools and strategies that support
    regulatory submission
  • Managing imaging data in global trials

Previous Attendee Acclaim:

This is a phenomenal experience to interact with and listen to best practices of industry colleagues.

Merck

CBI assembled a true group of experts that present the material in a way that was easy to understand and
generated great discussion.

Bayer

Great representation of various aspects (pharma + services). This is a great meeting to share best practices and network.

Cleveland Clinic

Greatly benefitted from this conference’s overall context from data management to read — very informative.

Stanford University